极低碳水饮食与DASH饮食在超重或肥胖合并高血压及糖尿病前期或2型糖尿病成人中的随机试验比较
该随机试验纳入94名来自密歇根东南部、同时患有高血压、糖尿病前期或2型糖尿病、超重或肥胖的成人,采用2×2饮食×支持 factorial 设计比较极低碳水饮食与DASH饮食。意向性分析显示,与DASH饮食相比,极低碳水饮食在4个月内对收缩压、糖化血红蛋白和体重的改善更显著,而额外支持措施无统计学显著影响。
要点
- 极低碳水饮食较DASH饮食更显著降低收缩压、改善糖化血红蛋白和减轻体重。
- 额外多组分支持(正念饮食、情绪调节、社会支持、烹饪)对结局无显著影响。
- 结果支持开展更大样本、更长随访的试验验证极低碳水饮食的疾病管理优势。
核心结论
- 对于高血压、糖尿病前期或2型糖尿病、超重或肥胖的成人,极低碳水饮食在4个月内对收缩压、血糖控制和体重的改善优于DASH饮食。
研究设计与样本
- 随机对照试验,纳入94名来自密歇根东南部、具有上述三重共病的成人,采用2×2饮食(极低碳水 vs DASH)×支持(有无多组分额外支持)析因设计,意向性分析。
主要发现
- 与DASH饮食相比,极低碳水饮食组估计平均收缩压改善更显著(-9.77 mm Hg vs -5.18 mm Hg;P = .046)。
- 极低碳水饮食组糖化血红蛋白改善更显著(-0.35% vs -0.14%;P = .034)。
- 极低碳水饮食组体重改善更显著(-19.14 lb vs -10.34 lb;P = .0003)。
- 额外支持对结局无统计学显著影响。
临床怎么用
- 对于高血压合并糖尿病前期或2型糖尿病及超重或肥胖的成人,可考虑将极低碳水饮食作为DASH饮食之外的一种饮食选择,但需在更大规模试验验证前个体化评估。
局限性
- 样本量较小(94人),随访期仅4个月,结果需更大规模、更长随访的试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adults with a triple multimorbidity (hypertension, prediabetes or type 2 diabetes, and overweight or obesity), are at increased risk of serious health complications, but experts disagree on which dietary patterns and support strategies should be recommended. METHODS: We randomized 94 adults from southeast Michigan with this triple multimorbidity using a 2 × 2 diet-by-support factorial design, comparing a very low-carbohydrate (VLC) diet vs a Dietary Approaches to Stop Hypertension (DASH) diet, as well as comparing results with and without multicomponent extra support (mindful eating, positive emotion regulation, social support, and cooking). RESULTS: Using intention-to-treat analyses, compared with the DASH diet, the VLC diet led to greater improvement in estimated mean systolic blood pressure (-9.77 mm Hg vs -5.18 mm Hg; P = .046), greater improvement in glycated hemoglobin (-0.35% vs -0.14%; P = .034), and greater improvement in weight (-19.14 lb vs -10.34 lb; P = .0003). The addition of extra support did not have a statistically significant effect on outcomes. CONCLUSIONS: For adults with hypertension, prediabetes or type 2 diabetes, and overweight or obesity, the VLC diet resulted in greater improvements in systolic blood pressure, glycemic control, and weight over a 4-month period compared with the DASH diet. These findings suggest that larger trials with longer follow-up are warranted to determine whether the VLC diet might be more beneficial for disease management than the DASH diet for these high-risk adults.
引用
- Saslow LR, Jones LM, Sen A, et al. Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial. Ann Fam Med. 2023. PMID: 37217318. doi:10.1370/afm.2968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。